ArticleBritish journal of cancer2025
An intelligent diagnostic model for pulmonary nodules utilizing chest radiographic imagery and its application in community-based lung cancer screening.
Article in British journal of cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Recent advances in artificial intelligence across interventional pulmonology: a narrative review.Journal of thoracic disease · 2026Review
- A transformer-based multimodal deep learning model for preoperative prediction of Ki-67 expression level in glioma.BMC medical imaging · 2026Article
- Determinants of the Public's Behavioral Intention to Adopt AI-Assisted Lung Cancer Screening: An Extended UTAUT Model Integrating Trust and Risk.Healthcare (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLung cancer is a health threat, particularly in regions where advanced screening methods like LDCT are limited. In China, chest X-rays (CXRs) are the primary tool for early detection. Integrating AI can enhance CXR diagnostic accuracy, addressing current challenges in early lung cancer detection.
methodsWe collected 4079 CXRs from 2518 individuals at TMUCIH. These were divided into a training set (1762 patients, 2965 images) and a validation set (756 patients, 1114 images). A deep learning (DL) model, based on the CXR-RANet architecture, was developed and validated using two external cohorts: 24,697 individuals (88,562 images) from the PLCO dataset and 4848 individuals from the ChestDR dataset. The model's performance was compared with mainstream DL algorithms and traditional machine learning (ML) model in feature extraction and classification.
resultsIn the TMUCIH dataset, 47.8% of patients had positive CXR results, compared to 3.9% in PLCO and 13.7% in ChestDR. The CXR-RANet model achieved an AUC of 0.933 in the internal validation set and 0.818 in the ChestDR dataset. In the PLCO dataset, it predicted lung cancer occurrence with AUCs of 0.902, 0.897, and 0.793 for 3, 5, and 10 years, respectively. The model outperformed mainstream DL algorithms in feature extraction and most ML algorithms in classification.
conclusionThe CXR-RANet presents a robust, scalable tool for diagnosing pulmonary nodules and lung cancer, enhancing the capabilities of community physicians in early detection and management, independent of expert experience. Its superior performance in feature extraction and classification underscores its value in lung cancer screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.